Table 2.
Father reported
|
Mother reported
|
||||||
---|---|---|---|---|---|---|---|
Cancer and age group (years) | Observed | Expected | Standardised incidence ratio (95% CI)* | Observed | Expected | Standardised incidence ratio (95% CI) * | |
All malignancies | |||||||
0-24 | 52 | 52.87 | 98 (73 to 129) | 12 | 12.47 | 96 (50 to 168) | |
0-14 | 36 | 36.50 | 99 (69 to 137) | 9 | 8.30 | 108 (50 to 206) | |
Leukaemia and non-Hodgkin’s lymphoma | |||||||
0-24 | 20 | 16.95 | 118 (72 to 182) | 5 | 3.92 | 127 (41 to 298) | |
0-14 | 18 | 14.01 | 128 (76 to 203) | 4 | 3.19 | 126 (34 to 321) | |
Leukaemia | |||||||
0-24 | 15 | 13.71 | 109 (61 to 180) | 3 | 3.17 | 95 (20 to 277) | |
0-14 | 14 | 11.96 | 117 (64 to 196) | 3 | 2.73 | 110 (23 to 321) | |
All malignancies except leukaemia and non-Hodgkin’s lymphoma | |||||||
0-24 | 32 | 35.95 | 89 (61 to 126 ) | 7 | 8.55 | 82 (33 to 169) | |
0-14 | 18 | 22.50 | 80 (47 to 126) | 5 | 5.12 | 98 (32 to 228) |
Adjusted for sex, age (5 year groups), and calendar period (single years).